These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34022414)

  • 1. Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial.
    Yonkus JA; Alva-Ruiz R; Abdelrahman AM; Leiting JL; Schneider AR; Grotz TE; Cleary SP; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Truty MJ
    J Am Coll Surg; 2021 Jul; 233(1):73-80.e1. PubMed ID: 34022414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas.
    Leick KM; Tomanek-Chalkley A; Coleman KL; Chan CHF
    Ann Surg Oncol; 2023 Oct; 30(11):6652-6660. PubMed ID: 37303025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma.
    Suenaga M; Fujii T; Yamada S; Hayashi M; Shinjo K; Takami H; Niwa Y; Sonohara F; Shimizu D; Kanda M; Kobayashi D; Tanaka C; Nakayama G; Koike M; Fujiwara M; Kondo Y; Kodera Y
    Ann Surg Oncol; 2021 Apr; 28(4):2277-2286. PubMed ID: 32875467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection.
    Kelly KJ; Wong J; Gladdy R; Moore-Dalal K; Woo Y; Gonen M; Brennan M; Allen P; Fong Y; Coit D
    Ann Surg Oncol; 2009 Dec; 16(12):3333-9. PubMed ID: 19763694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yield of Staging Laparoscopy for Pancreatic Cancer in the Modern Era: Analysis of More than 1,000 Consecutive Patients.
    Gudmundsdottir H; Yonkus JA; Alva-Ruiz R; Kendrick ML; Smoot RL; Warner SG; Starlinger P; Thiels CA; Nagorney DM; Cleary SP; Grotz TE; Truty MJ
    J Am Coll Surg; 2023 Jul; 237(1):49-57. PubMed ID: 37026837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.
    Allenson K; Castillo J; San Lucas FA; Scelo G; Kim DU; Bernard V; Davis G; Kumar T; Katz M; Overman MJ; Foretova L; Fabianova E; Holcatova I; Janout V; Meric-Bernstam F; Gascoyne P; Wistuba I; Varadhachary G; Brennan P; Hanash S; Li D; Maitra A; Alvarez H
    Ann Oncol; 2017 Apr; 28(4):741-747. PubMed ID: 28104621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse-transcription polymerase chain reaction identifies patients at high risk for peritoneal recurrence and consequent impaired survival in the setting of preoperative chemoradiation therapy for pancreatic cancer.
    Takahashi H; Akita H; Wada H; Tomokuni A; Asukai K; Takahashi Y; Yanagimoto Y; Matsunaga T; Sugimura K; Yamamoto K; Nishimura J; Yasui M; Omori T; Miyata H; Yamamoto T; Nakanishi M; Shirayanagi M; Yamasaki T; Ohue M; Yano M; Sakon M; Ishikawa O
    Surgery; 2018 Dec; 164(6):1168-1177. PubMed ID: 30146098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y
    Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Implications of Multiplex Detection of
    Kim MK; Woo SM; Park B; Yoon KA; Kim YH; Joo J; Lee WJ; Han SS; Park SJ; Kong SY
    Clin Chem; 2018 Apr; 64(4):726-734. PubMed ID: 29352043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma.
    Sergeant G; Roskams T; van Pelt J; Houtmeyers F; Aerts R; Topal B
    BMC Cancer; 2011 Jan; 11():47. PubMed ID: 21281486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopy and peritoneal cytology in the staging of pancreatic cancer.
    Jimenez RE; Warshaw AL; Fernandez-Del Castillo C
    J Hepatobiliary Pancreat Surg; 2000; 7(1):15-20. PubMed ID: 10982586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant
    Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
    Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS mutation allele frequency threshold alters prognosis in right-sided resected pancreatic cancer.
    Nauheim D; Moskal D; Renslo B; Chadwick M; Jiang W; Yeo CJ; Nevler A; Bowne W; Lavu H
    J Surg Oncol; 2022 Aug; 126(2):314-321. PubMed ID: 35333412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-194-5p in Pancreatic Ductal Adenocarcinoma Peritoneal Washings is Associated with Peritoneal Recurrence and Overall Survival in Peritoneal Cytology-Negative Patients.
    Kubo H; Hiroshima Y; Mori R; Saigusa Y; Murakami T; Yabushita Y; Sawada Y; Homma Y; Kumamoto T; Matsuyama R; Endo I
    Ann Surg Oncol; 2019 Dec; 26(13):4506-4514. PubMed ID: 31489551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS mutations in pancreatic circulating tumor cells: a pilot study.
    Kulemann B; Liss AS; Warshaw AL; Seifert S; Bronsert P; Glatz T; Pitman MB; Hoeppner J
    Tumour Biol; 2016 Jun; 37(6):7547-54. PubMed ID: 26684803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy.
    Hata T; Mizuma M; Masuda K; Chiba K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Unno M
    Ann Surg Oncol; 2021 Apr; 28(4):2235-2245. PubMed ID: 33393045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incremental benefit of two quadrant lavage for peritoneal cytology at staging laparoscopy for oesophagogastric adenocarcinoma.
    Munasinghe A; Kazi W; Taniere P; Hallissey MT; Alderson D; Tucker O
    Surg Endosc; 2013 Nov; 27(11):4049-53. PubMed ID: 23836122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer.
    Pak LM; Coit DG; Eaton AA; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Strong VE; Kingham TP
    Ann Surg Oncol; 2017 May; 24(5):1174-1179. PubMed ID: 28058561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma.
    Karabicak I; Satoi S; Yanagimoto H; Yamamoto T; Hirooka S; Yamaki S; Kosaka H; Inoue K; Matsui Y; Kon M
    J Hepatobiliary Pancreat Sci; 2016 Dec; 23(12):750-755. PubMed ID: 27794194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal exfoliative cytology and Ki-ras mutational analysis in patients with pancreatic adenocarcinoma.
    Rall CJ; Rivera JA; Centeno BA; Fernandez-del Castillo C; Rattner DW; Warshaw AL; Rustgi AK
    Cancer Lett; 1995 Nov; 97(2):203-11. PubMed ID: 7497464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.